Inadequate Triglyceride Management Worsens the Durability of Dipeptidyl Peptidase-4 Inhibitor in Subjects with Type 2 Diabetes Mellitus

Figure 1

(a) Alteration of HbA1c levels after starting DPP-4 inhibitor in all participants (overall trend: ). versus baseline; ^# versus baseline. Data are shown as mean ± SD. (b) Alteration of HbA1c levels after starting DPP-4 inhibitor in the effective group (solid line) (overall trend: ) and the ineffective group (dashed line) (overall trend: ). versus the ineffective group at the same time point; ^# versus baseline in the effective group. Data are shown as mean ± SD.

(a)

(b)